Promedior's Debt Round

Promedior raised a round of funding on October 17, 2011.

Promedior is a clinical stage immunotherapy company pioneering the development of targeted therapeutics to treat diseases involving fibrosis. Fibrosis occurs when healthy tissue is replaced with exces…

Articles about Promedior's Debt Round: